Opyl (ASX:OPL) collabs with Consentic, launches research screening service

2 min read | September 29, 2022 10:44 AM AEST | By Team Kalkine Media

Google News:

Opyl (ASX:OPL) collabs with Consentic, launches research screening service — Image source: © Nandoonline | Megapixl.com

Recent News

Southern Cross Electrical (ASX:SXE): Why Is This Industrial Stock Sudd...

Berkeley Energia (ASX:BKY): Are These Overlooked Penny Stocks Worth Wa...

Woodside (ASX:WDS): Could These Dividend Shares Add More Income to Sup...

Telstra (ASX:TLS): The Retirement Income Formula Hiding in Plain Sight...

Make Kalkine Media
My Trusted Source

Highlights:

Opyl has collaborated with e-consent platform, Consentic, for tipping up enrolment and recruitment revenues.

The company has also launched a new personalised research screening service for its flagship platform.

Opyl is aiming to achieve three-digit growth in the global clinical trial market.

AI-assisted MedTech company, Opyl Limited’s (ASX:OPL) flagship patient-led platform, Opin, made two crucial announcements on 28 September 2022. Opin inked a deal with an online video-based electronic clinical trial consent (e-consent) platform named Consentic alongside the launch of its new expert research screening service. Both announcements are a step towards increasing trial enrolment, participant experience, and business revenues of Opyl, as per the company.

Meanwhile, on 29 September, the shares of the company were spotted trading at AU$0.050 per share at 10:10 AM AEST on ASX.

Talking about the development, Oply CEO Michelle Gallaher said,

How will this partnership help Opyl?

Partnering with Consentic and launching new research screening services will directly influence and control the enrolment and recruitment value chain of Opin.
Both initiatives will work together to drive improvement in customer acquisition and market share in order to accelerate revenue growth.
Through this partnership, Opyl aims to achieve its goal of reaching triple-digit growth in the vast global clinical trial market.

Rebecca Saunderson (Consentic CEO) made a statement about this partnership:

Things to know about Opin’s new screening service

Opin’s new expert research screening service develops personalised contact with participants via phone, SMS, or email while accurately triaging them. Once participants pass the initial digital screening round, Opin pre-qualifies them to participate in a study while improving enrolment and consent probability.

This technological innovation simply results in increased enrolment, better participant satisfaction, better value for consumers, and ultimately, more profitability for Opyl, as per the company.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.